243 related articles for article (PubMed ID: 33030333)
1. Covert Pathways to the Cranial Cavity: Could These Be Potential Routes of SARS-CoV-2 to the Brain?
Baig AM
ACS Chem Neurosci; 2020 Oct; 11(20):3185-3187. PubMed ID: 33030333
[TBL] [Abstract][Full Text] [Related]
2. COVID-19: a conundrum to decipher.
Deshmukh V; Tripathi SC; Pandey A; Deshmukh V; Vykoukal J; Patil A; Sontakke B
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5830-5841. PubMed ID: 32495923
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 Targeting the Retina: Host-virus Interaction and Possible Mechanisms of Viral Tropism.
de Figueiredo CS; Raony Í; Giestal-de-Araujo E
Ocul Immunol Inflamm; 2020 Nov; 28(8):1301-1304. PubMed ID: 32946292
[No Abstract] [Full Text] [Related]
4. SARS-CoV-2, More than a Respiratory Virus: Its Potential Role in Neuropathogenesis.
Singal CMS; Jaiswal P; Seth P
ACS Chem Neurosci; 2020 Jul; 11(13):1887-1899. PubMed ID: 32491829
[TBL] [Abstract][Full Text] [Related]
5. Genetic Hypothesis and Pharmacogenetics Side of Renin-Angiotensin-System in COVID-19.
Gemmati D; Tisato V
Genes (Basel); 2020 Sep; 11(9):. PubMed ID: 32899439
[TBL] [Abstract][Full Text] [Related]
6. Possible routes of SARS-CoV-2 invasion in brain: In context of neurological symptoms in COVID-19 patients.
Kumar A; Pareek V; Prasoon P; Faiq MA; Kumar P; Kumari C; Narayan RK
J Neurosci Res; 2020 Dec; 98(12):2376-2383. PubMed ID: 32869376
[TBL] [Abstract][Full Text] [Related]
7. [Neurological aspects of the COVID-19 pandemic caused by the SARS-CoV-2 coronavirus].
Bereczki D; Stang R; Böjti P; Kovács T
Ideggyogy Sz; 2020 May; 73(05-06):171-175. PubMed ID: 32579306
[TBL] [Abstract][Full Text] [Related]
8. Potential neurological effects of severe COVID-19 infection.
Nuzzo D; Picone P
Neurosci Res; 2020 Sep; 158():1-5. PubMed ID: 32628969
[TBL] [Abstract][Full Text] [Related]
9. Neurological manifestations of COVID-19: A brief review.
Sachdev K; Agrawal S; Ish P; Gupta N; Raheja K
Indian J Med Res; 2020 Jul & Aug; 152(1 & 2):41-47. PubMed ID: 32859864
[TBL] [Abstract][Full Text] [Related]
10. Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome.
van de Veerdonk FL; Netea MG; van Deuren M; van der Meer JW; de Mast Q; Brüggemann RJ; van der Hoeven H
Elife; 2020 Apr; 9():. PubMed ID: 32338605
[TBL] [Abstract][Full Text] [Related]
11. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and the Central Nervous System.
De Felice FG; Tovar-Moll F; Moll J; Munoz DP; Ferreira ST
Trends Neurosci; 2020 Jun; 43(6):355-357. PubMed ID: 32359765
[TBL] [Abstract][Full Text] [Related]
12. Updates on What ACS Reported: Emerging Evidences of COVID-19 with Nervous System Involvement.
Baig AM
ACS Chem Neurosci; 2020 May; 11(9):1204-1205. PubMed ID: 32343122
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Binding to ACE2 Receptors from Human, Pets, Farm Animals, and Putative Intermediate Hosts.
Zhai X; Sun J; Yan Z; Zhang J; Zhao J; Zhao Z; Gao Q; He WT; Veit M; Su S
J Virol; 2020 Jul; 94(15):. PubMed ID: 32404529
[TBL] [Abstract][Full Text] [Related]
14. Replication of Severe Acute Respiratory Syndrome Coronavirus 2 in Human Respiratory Epithelium.
Milewska A; Kula-Pacurar A; Wadas J; Suder A; Szczepanski A; Dabrowska A; Owczarek K; Marcello A; Ochman M; Stacel T; Rajfur Z; Sanak M; Labaj P; Branicki W; Pyrc K
J Virol; 2020 Jul; 94(15):. PubMed ID: 32434888
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 strategically mimics proteolytic activation of human ENaC.
Anand P; Puranik A; Aravamudan M; Venkatakrishnan AJ; Soundararajan V
Elife; 2020 May; 9():. PubMed ID: 32452762
[TBL] [Abstract][Full Text] [Related]
16. Atypical lymphocyte morphology in SARS-CoV-2 infection.
El Jamal SM; Salib C; Stock A; Uriarte-Haparnas NI; Glicksberg BS; Teruya-Feldstein J; Dembitzer FR; Nadkarni GN; Firpo-Betancourt A
Pathol Res Pract; 2020 Sep; 216(9):153063. PubMed ID: 32825937
[No Abstract] [Full Text] [Related]
17. Correlation between CNS Tuberculosis and the COVID-19 Pandemic: The Neurological and Therapeutic Insights.
Mandal N; De N; Jana P; Sannigrahi A; Chattopadhyay K
ACS Chem Neurosci; 2020 Sep; 11(18):2789-2792. PubMed ID: 32880441
[TBL] [Abstract][Full Text] [Related]
18. Neurological manifestations of patients with COVID-19: potential routes of SARS-CoV-2 neuroinvasion from the periphery to the brain.
Li Z; Liu T; Yang N; Han D; Mi X; Li Y; Liu K; Vuylsteke A; Xiang H; Guo X
Front Med; 2020 Oct; 14(5):533-541. PubMed ID: 32367431
[TBL] [Abstract][Full Text] [Related]
19. First case of SARS-COV-2 sequencing in cerebrospinal fluid of a patient with suspected demyelinating disease.
Domingues RB; Mendes-Correa MC; de Moura Leite FBV; Sabino EC; Salarini DZ; Claro I; Santos DW; de Jesus JG; Ferreira NE; Romano CM; Soares CAS
J Neurol; 2020 Nov; 267(11):3154-3156. PubMed ID: 32564153
[TBL] [Abstract][Full Text] [Related]
20. Is the Collapse of the Respiratory Center in the Brain Responsible for Respiratory Breakdown in COVID-19 Patients?
Gandhi S; Srivastava AK; Ray U; Tripathi PP
ACS Chem Neurosci; 2020 May; 11(10):1379-1381. PubMed ID: 32348111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
